NCT03420586View on ClinicalTrials.gov

Nitrous Oxide Added at the End of Sevoflurane Anesthesia and Recovery

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

February 7, 2018

Primary Completion Date

July 10, 2021

Study Completion Date

July 25, 2021

Conditions
Elective Surgical ProceduresLaparoscopyLaparotomyAnesthesia, GeneralAnesthesia Recovery Period
Interventions
DRUG

Nitrous Oxide

The nitrous oxide group (GN2O) will receive 70% N2O in 30% O2 at the end of surgery.

Trial Locations (1)

23000

General Hospital Zadar, Zadar

All Listed Sponsors
lead

General Hospital Zadar

OTHER

NCT03420586 - Nitrous Oxide Added at the End of Sevoflurane Anesthesia and Recovery | Biotech Hunter | Biotech Hunter